Protective role of dispercam against adverse effects of cefotaxime on lipid peroxidation and the activities of lipoxygenase and some antioxidant enzymes
Journal of the Medical Research Institute-Alexandria University. 1999; 20 (4): 48-56
Dans Anglais
| IMEMR
| ID: emr-51101
ABSTRACT
Malondialdehyde [MDA] level and the activities of superoxide dismutase [SOD], catalase and lipoxygenase were determined in liver of guinea pigs treated with 1-Cefotaxime, 2-[Cefotaxime plus dispercam], 3- dispercam, and compared their results with the control data. Cefotaxime increased both the level of MDA and the activities of SOD, catalase and lipoxygenase enzymes as compared with the normal control data. However, the treatment of guinea pigs with cefataxime plus dispercam decreased both level of MDA and the activities of SOD, catalase and lipoxygenase enzymes as compared with the data of cefotaxime treatment, i.e., Dispercam treatment decreased the side effects of cefotaxime treatment. The results also showed that, the treatment with dispercam only decrease the activities of SOD, catalase and lipoxygenase and also the level of MDA as compared with the normal control data
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Superoxide dismutase
/
Peroxydation lipidique
/
Catalase
/
Lipoxygenase
/
Agents protecteurs
/
Cochons d'Inde
/
Malonaldéhyde
/
Antioxydants
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
J. Med. Res. Inst.-Alex. Univ.
Année:
1999
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS